You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.

In addition to all the activities Kedrion undertakes to research, develop and market its plasma-derived products, it also offers a range of services to interested external partners and collaborators worldwide:

First among these – and a model for future collaborations worldwide – is our partnership with the Italian National Health Service, for which we provide a fundamental partnership at all levels of operation in establishing self-sufficiency in plasma-derived therapies.

In addition, both inside and outside Italy, Kedrion offers prospective partners and collaborators:

  • Contract Manufacturing, through which we take on a variety of activities (e.g., plasma fractionation, product research and development) for other companies and countries, often while helping them to develop their own capacities.
  • Technology Transfer to support the development of domestic self-sufficiency for the manufacture of plasma-derived products.
  • Services of the Biological Safety Centre in establishing and maintaining highest levels of safety within the pharmaceutical and other biological sectors.